Although shortages periodically capture national attention when widely used agents such as cisplatin or carboplatin become scarce, the problem extends well beyond any single drug.

Global Burden of Disease data showed alcohol-attributable cancer deaths in the US doubled from 1990 to 2023, with liver cancer showing the steepest rise.

“Far and away, a unified electronic health record is the single use case that could benefit both patients and physicians most, and AI has the potential to help us achieve that,” said Margarita Racsa, MD, MPH.

Nevine Hanna, MD, MPH, FACRO, DABR, detailed how AI auto-contouring and adaptive planning improve efficiency and organ-at-risk sparing in radiation therapy.

How do we implement AI in a way that serves patients? Expert radiation oncologists discuss the crucial question.

Nevine Hanna, MD, MPH, FACRO, DABR, explained how AI can aggregate patient data to enhance multidisciplinary tumor board collaboration.

According to Margarita Racsa, MD, MPH, patients coming in with AI-informed insights can be a double-edged sword for clinicians.